Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0955
0.00 (0.00%)
Apr 16, 2024, 2:55 PM EDT - Market closed

Nascent Biotech Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016201520142013 2012
Revenue
010.750003000
Upgrade
Revenue Growth (YoY)
-33.33%--------
Upgrade
Gross Profit
010.750003000
Upgrade
Selling, General & Admin
1.490.931.833.151.111.031.574.290.470.19
Upgrade
Research & Development
0.270.20.320.290.251.190.491.151.670.38
Upgrade
Other Operating Expenses
1.50.33-0000-0.48-1.57-0.021.34
Upgrade
Operating Expenses
2.141.462.153.451.372.221.573.872.121.91
Upgrade
Operating Income
-2.16-0.46-1.4-3.45-1.37-2.221.43-3.87-2.12-1.91
Upgrade
Interest Income
0000000000
Upgrade
Interest Expense
1.720.340.340.09000.050.280.02-0.01
Upgrade
Other Expense / Income
-3.29-0.32-0.780.4700-0-00.010.02
Upgrade
Pretax Income
-2.8-0.47-0.96-4-1.37-2.221.38-4.15-2.15-1.92
Upgrade
Income Tax
2.21-0.320.360.09-0-00.24-00.010.02
Upgrade
Net Income
-2.8-0.15-1.31-4.09-1.37-2.221.14-4.15-2.16-1.94
Upgrade
Shares Outstanding (Basic)
1191087234302622201417
Upgrade
Shares Outstanding (Diluted)
1191087234302622201417
Upgrade
Shares Change
10.05%48.93%110.34%14.30%16.25%18.74%10.26%41.32%-19.18%-
Upgrade
EPS (Basic)
-0.02-0.00-0.02-0.12-0.05-0.090.05-0.21-0.15-0.11
Upgrade
EPS (Diluted)
-0.02-0.00-0.02-0.12-0.05-0.090.05-0.21-0.15-0.11
Upgrade
Free Cash Flow
-1.790.41-0.99-0.55-0.71-1.22-0.77-0.17-1.3-0.13
Upgrade
Free Cash Flow Per Share
-0.020.00-0.01-0.02-0.02-0.05-0.04-0.01-0.09-0.01
Upgrade
Gross Margin
-100.00%100.00%---100.00%---
Upgrade
Operating Margin
--45.71%-186.72%---47.58%---
Upgrade
Profit Margin
--14.77%-175.31%---37.90%---
Upgrade
Free Cash Flow Margin
-41.35%-131.57%----25.63%---
Upgrade
Effective Tax Rate
------17.43%---
Upgrade
EBITDA
-2.16-0.61-1.42-3.45-1.37-2.221.43-3.87-2.13-1.93
Upgrade
EBITDA Margin
--60.82%-189.35%---47.59%---
Upgrade
Depreciation & Amortization
1.34000000000
Upgrade
EBIT
-3.5---------
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.